The Alcor Podcast

Shelby Calkins, Alcor's Medical Response Director, gives insights into the workings of the Deployment and Recovery Team (DART). She discusses their shift to in-house operations and the dramatic rise in annual case volume. Shelby covers critical equipment deployment and emergency protocols, emphasizing the importance of member communication. Team dynamics and the need for a diverse skill set are also highlighted, showcasing how meticulous planning ensures successful cryopreservation outcomes. Her passion for educational improvements reinforces the team's readiness for future challenges.

Shelby Calkins, Alcor's Medical Response Director and lead of the Deployment and Recovery Team (DART), shares fascinating insights into the vital operations of her team. She discusses the history and evolution of Alcor’s approach to Standby Stabilization and Transport. Listeners will learn about the crucial differences between cryopreservation techniques and why specialized training is essential. Calkins also addresses common misconceptions and highlights the importance of adapting care to individual cases, while emphasizing soft skills vital for team success.

Jeremy Wiggins, Alcor's International Development Coordinator and a board member of Alcor Canada, discusses the establishment of Alcor Canada and its mission to enhance cryonics accessibility. He shares insights into the DART team's operations and the training necessary for effective cryopreservation. The conversation explores innovative surgical practices and the importance of respectful treatment of the deceased in collaboration with funeral homes. With a robust donor-supported model, Wiggins highlights future ambitions for growth and localized cryonics resources.

Jeremy Wiggins, Alcor's International Development Coordinator and board member from Alcor Canada, dives deep into the exciting expansion plans for Alcor in Europe. He highlights Sweden as the top location due to its stability and educated workforce. Wiggins discusses challenges like recruitment and the need for rapid construction, aiming for a new facility within a year. He also emphasizes the urgent need for financial support, with goals of raising $3 to $5 million, and innovative funding methods such as cryptocurrency to bring Alcor to Europe.

James Arrowood, CEO of Alcor Life Extension Foundation, shares exciting developments at Alcor, as they embark on their largest expansion yet. He discusses strategic hiring to enhance team capabilities, including key roles in research and emergency response. The conversation highlights new initiatives aimed at improving member services and the impact of international outreach into Canada and Europe. Arrowood emphasizes the importance of community support and donations to drive Alcor's mission and innovate future cryonics research.